This present study suggests that PON2 is overexpressed in early stages of ovarian cancer in human subjects (Fig. 1a, b) and its expression is negatively associated with tumor size and volume (Fig. 3a–c) in a mouse model. This evidence concerns the gene PON2 and ovarian carcinoma.